Search research articles
Contact Us
Filters
Showing results (81-90 of 165) with videos related to
Page
of 17
Sort By:
Diabetes
|
September 12, 2012
The core cysteines, (C909) of islet antigen-2 and (C945) of islet antigen-2β, are crucial to autoantibody binding in type 1 diabetes
Karen T Elvers, Ivey Geoghegan, Debbie K Shoemark, et al.
Diabetes Care
|
March 22, 2018
Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes
Polly J Bingley, Diane K Wherrett, Ann Shultz, et al.
Journal of Immunological Methods
|
November 11, 1999
Evaluation of a high-throughput second antibody radiobinding assay for measuring IgA antibodies to human tissue transglutaminase
A J Williams, P Annis, R J Lock, et al.
Diabetes Care
|
February 24, 2001
Proposed guidelines on screening for risk of type 1 diabetes
P J Bingley, E Bonifacio, A G Ziegler, et al.
Diabetes Care
|
September 28, 2001
Proinsulin-specific autoantibodies are relatively infrequent in young offspring with pre-type 1 diabetes
M Hummel, A J Williams, A Norcross, et al.
Clinical Immunology (Orlando, Fla.)
|
October 25, 2006
Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program
Peter Achenbach, Michael Schlosser, Alistair J K Williams, et al.
Spinal Cord
|
August 5, 2004
Do spinal cord injury patients always get the best treatment for neuropathic bladder after discharge from regional spinal injuries centre?
S Vaidyanathan, G Singh, B M Soni, et al.
Clinical and Experimental Immunology
|
December 3, 2011
'Insulin autoantibody affinity measurement using a single concentration of unlabelled insulin competitor discriminates risk in relatives of patients with type 1 diabetes
R M Curnock, C R Reed, S Rokni, et al.
Diabetes
|
May 24, 2015
Reactivity to N-Terminally Truncated GAD65(96-585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 Diabetes
Alistair J K Williams, Vito Lampasona, Rebecca Wyatt, et al.
Diabetologia
|
October 5, 2006
Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives
P Achenbach, K Warncke, J Reiter, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 165) with videos related to
Sort By:
Page
of 17
Diabetes
|
September 12, 2012
The core cysteines, (C909) of islet antigen-2 and (C945) of islet antigen-2β, are crucial to autoantibody binding in type 1 diabetes
Karen T Elvers, Ivey Geoghegan, Debbie K Shoemark, et al.
Diabetes Care
|
March 22, 2018
Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes
Polly J Bingley, Diane K Wherrett, Ann Shultz, et al.
Journal of Immunological Methods
|
November 11, 1999
Evaluation of a high-throughput second antibody radiobinding assay for measuring IgA antibodies to human tissue transglutaminase
A J Williams, P Annis, R J Lock, et al.
Diabetes Care
|
February 24, 2001
Proposed guidelines on screening for risk of type 1 diabetes
P J Bingley, E Bonifacio, A G Ziegler, et al.
Diabetes Care
|
September 28, 2001
Proinsulin-specific autoantibodies are relatively infrequent in young offspring with pre-type 1 diabetes
M Hummel, A J Williams, A Norcross, et al.
Clinical Immunology (Orlando, Fla.)
|
October 25, 2006
Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program
Peter Achenbach, Michael Schlosser, Alistair J K Williams, et al.
Spinal Cord
|
August 5, 2004
Do spinal cord injury patients always get the best treatment for neuropathic bladder after discharge from regional spinal injuries centre?
S Vaidyanathan, G Singh, B M Soni, et al.
Clinical and Experimental Immunology
|
December 3, 2011
'Insulin autoantibody affinity measurement using a single concentration of unlabelled insulin competitor discriminates risk in relatives of patients with type 1 diabetes
R M Curnock, C R Reed, S Rokni, et al.
Diabetes
|
May 24, 2015
Reactivity to N-Terminally Truncated GAD65(96-585) Identifies GAD Autoantibodies That Are More Closely Associated With Diabetes Progression in Relatives of Patients With Type 1 Diabetes
Alistair J K Williams, Vito Lampasona, Rebecca Wyatt, et al.
Diabetologia
|
October 5, 2006
Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives
P Achenbach, K Warncke, J Reiter, et al.
Page
of 17